Targets › SELL
1 program from 1 company in 2 trials: 2 Phase 2; Other; next expected readout Oct 2029.
Calcium-dependent lectin that mediates cell adhesion by binding to glycoproteins on neighboring cells. Mediates the adherence of lymphocytes to endothelial cells of high endothelial venules in peripheral lymph nodes. (UniProt, P14151)
Open in Phaseline: the race on SELL, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Hong Kong Children's Hospital | CD62L depleted donor lymphocyte infusion CD62L-depleted donor lymphocytes for T cell reconstitution and graft-versus-tumor effect | SELL | Phase 2 | Hematopoietic Organs; Disorder; Hematopoietic Cell Transplantation | Oct 2029 |
Hematopoietic Organs; Disorder (1) Hematopoietic Cell Transplantation (1)
protein or peptide (1)
Hong Kong Children's Hospital (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.